Westpac Banking Corp increased its holdings in HCA Healthcare Inc (NYSE:HCA) by 8.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 312,157 shares of the company’s stock after purchasing an additional 23,437 shares during the period. HCA Healthcare accounts for 0.7% of Westpac Banking Corp’s investment portfolio, making the stock its 23rd biggest position. Westpac Banking Corp’s holdings in HCA Healthcare were worth $40,699,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the company. Benjamin F. Edwards & Company Inc. acquired a new position in shares of HCA Healthcare during the 4th quarter worth approximately $25,000. Sontag Advisory LLC bought a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $26,000. Doyle Wealth Management bought a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $31,000. Financial Gravity Wealth Inc. bought a new stake in shares of HCA Healthcare during the 1st quarter worth approximately $47,000. Finally, JOYN Advisors Inc. lifted its holdings in shares of HCA Healthcare by 83.3% during the 4th quarter. JOYN Advisors Inc. now owns 460 shares of the company’s stock worth $57,000 after acquiring an additional 209 shares during the period. 70.29% of the stock is owned by institutional investors and hedge funds.

Shares of HCA traded down $1.80 during trading hours on Wednesday, hitting $126.24. 808,051 shares of the stock were exchanged, compared to its average volume of 1,793,874. HCA Healthcare Inc has a fifty-two week low of $101.30 and a fifty-two week high of $147.42. The stock has a market cap of $42.91 billion, a PE ratio of 12.92, a price-to-earnings-growth ratio of 1.03 and a beta of 0.76.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, April 30th. The company reported $2.97 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.31 by $0.66. HCA Healthcare had a net margin of 7.71% and a negative return on equity of 112.65%. The company had revenue of $12.52 billion during the quarter, compared to analysts’ expectations of $12.34 billion. During the same period in the prior year, the company posted $3.18 earnings per share. HCA Healthcare’s revenue for the quarter was up 9.6% compared to the same quarter last year. On average, equities research analysts anticipate that HCA Healthcare Inc will post 10.4 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Monday, June 3rd will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 1.27%. The ex-dividend date of this dividend is Friday, May 31st. HCA Healthcare’s payout ratio is 16.38%.

A number of analysts have recently weighed in on HCA shares. Raymond James raised shares of HCA Healthcare from a “market perform” rating to an “outperform” rating and upped their price target for the stock from $115.00 to $135.00 in a report on Tuesday, April 23rd. UBS Group increased their price objective on shares of HCA Healthcare from $164.00 to $172.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. Deutsche Bank increased their price objective on shares of HCA Healthcare from $160.00 to $165.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. Barclays dropped their price objective on shares of HCA Healthcare from $155.00 to $145.00 and set an “overweight” rating for the company in a research note on Wednesday, April 17th. Finally, ValuEngine downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, March 6th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and eighteen have issued a buy rating to the company. HCA Healthcare presently has an average rating of “Buy” and an average price target of $149.00.

In other HCA Healthcare news, insider Jon M. Foster sold 44,281 shares of the firm’s stock in a transaction on Friday, May 10th. The shares were sold at an average price of $122.28, for a total value of $5,414,680.68. Following the completion of the sale, the insider now directly owns 96,052 shares in the company, valued at $11,745,238.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 2.70% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “HCA Healthcare Inc (NYSE:HCA) Stake Raised by Westpac Banking Corp” was published by Watch List News and is owned by of Watch List News. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international copyright & trademark laws. The original version of this piece can be read at https://www.watchlistnews.com/hca-healthcare-inc-nysehca-stake-raised-by-westpac-banking-corp/3039595.html.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

See Also: Stochastic Momentum Index (SMI)

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.